Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase

被引:75
|
作者
Prime, Michael E. [1 ]
Courtney, Stephen M. [1 ]
Brookfield, Frederick A. [1 ]
Marston, Richard W. [1 ]
Walker, Victoria [1 ]
Warne, Justin [1 ]
Boyd, Andrew E.
Kairies, Norman A. [3 ]
von der Saal, Wolfgang [2 ]
Limberg, Anja [2 ]
Georges, Guy [2 ]
Engh, Richard A. [3 ]
Goller, Bernhard [2 ]
Rueger, Petra [2 ]
Rueth, Matthias [2 ]
机构
[1] Evotec UK Ltd, Abingdon OX14 4SA, Oxon, England
[2] Roche Diagnost GmbH, Pharma Res Penzberg, D-82372 Penzberg, Germany
[3] Max Planck Inst Biochem, D-82152 Planegg Martinsried, Germany
关键词
AURORA/IP11-RELATED PROTEIN-KINASE; SMALL-MOLECULE INHIBITOR; IN-VIVO; ANTICANCER AGENTS; B KINASE; SPINDLE; CELLS; CYTOKINESIS; CHECKPOINT; DISCOVERY;
D O I
10.1021/jm101346r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scoff old The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically > 1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680
引用
收藏
页码:312 / 319
页数:8
相关论文
共 50 条
  • [1] Discovery of orally bioavailable Aurora kinase inhibitors
    Zhang, Yonglian
    Yu, Tao
    Tagat, Jayaram R.
    Xiao, Yushi
    Kerekes, Angela D.
    Doll, Ronald J.
    Esposite, Sara
    Hruza, Alan
    Voss, Matthew
    Rainka, Matthew
    Basso, Andrea D.
    Gray, Kimberly
    Tevar, Seema
    Kirschmeier, Paul
    Liu, Ming
    Liang, Lianzhu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [2] Discovery of orally bioavailable Aurora kinase inhibitors
    Belanger, David B.
    Williams, Michael J.
    Meng, Zhaoyang
    Yu, Tao
    Mandal, Amit K.
    Curran, Patrick J.
    Rainka, Matthew P.
    Shih, Neng-Yang
    Siddiqui, M. Arshad
    Basso, Andrea D.
    Prelusky, Daniel
    Liu, Ming
    Lee, Suining
    Yaremko, Bohdan
    Gray, Kimberly
    Tevar, Seema
    Jones, Jennifer
    Smith, Elizabeth B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [3] Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor
    Cee, Victor J.
    Schenkel, Laurie B.
    Hodous, Brian L.
    Deak, Holly L.
    Nguyen, Hanh N.
    Olivieri, Philip R.
    Romero, Karina
    Bak, Annette
    Be, Xuhai
    Bellon, Steve
    Bush, Tammy L.
    Cheng, Alan C.
    Chung, Grace
    Coats, Steve
    Eden, Patrick M.
    Hanestad, Kelly
    Gallant, Paul L.
    Gu, Yan
    Huang, Xin
    Kendall, Richard L.
    Lin, Min-Hwa Jasmine
    Morrison, Michael J.
    Patel, Vinod F.
    Radinsky, Robert
    Rose, Paul E.
    Ross, Sandra
    Sun, Ji-Rong
    Tang, Jin
    Zhao, Huilin
    Payton, Marc
    Geuns-Meyer, Stephanie D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6368 - 6377
  • [4] MEDI 357-Aminobenzimidazole derivatives as selective and orally bioavailable inhibitors of Aurora B kinase
    Romero, Karina
    Bellon, Steve
    Beltran, Pedro J.
    Berry, Loren M.
    Cee, Victor J.
    Chung, Grace Y.
    Coats, Steve
    Cooke, Melanie W.
    Deak, Holly L.
    Eden, Patrick M.
    Fretland, Jenne
    Gallant, Paul
    Green, David W.
    Gu, Yan
    Hodous, Brian L.
    Huang, Xin
    Kendall, Richard
    Kim, Joseph L.
    Lin, Jasmine
    Morrison, Michael
    Nguyen, Hanh N.
    Olivieri, Philip R., II
    Patel, Vikram
    Patel, Vinod F.
    Powers, David
    Radinsky, Robert
    Rose, Paul
    Wong, Andrew
    Zhao, Huilin
    Payton, Marc N.
    Geuns-Meyer, Stephanie D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [5] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
    Grimster, Neil P.
    Gingipalli, Lakshmaiah
    Barlaam, Bernard
    Su, Qibin
    Zheng, XiaoLan
    Watson, David
    Wang, Haixia
    Simpson, Iain
    Pike, Andy
    Balazs, Amber
    Boiko, Scott
    Ikeda, Timothy P.
    Impastato, Anna C.
    Jones, Natalie H.
    Kawatkar, Sameer
    Kemmitt, Paul
    Lamont, Scott
    Patel, Joe
    Read, Jon
    Sarkar, Ujjal
    Sha, Li
    Tomlinson, Ronald C.
    Wang, Haiyun
    Wilson, David M.
    Zehnder, Troy E.
    Wang, Lianghe
    Wang, Peng
    Goldberg, Frederick W.
    Shao, Wenlin
    Fawell, Stephen
    Dry, Hannah
    Dowling, James E.
    Edmondson, Scott D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
  • [6] Aminopyridines: selective Aurora-A inhibitors
    Vianello, Paola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (02) : 255 - 261
  • [7] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
    Parthasarathy, Saravanan
    Henry, Kenneth
    Pei, Huaxing
    Clayton, Josh
    Rempala, Mark
    Johns, Deidre
    De Frutos, Oscar
    Garcia, Pablo
    Mateos, Carlos
    Pleite, Sehila
    Wang, Yong
    Stout, Stephanie
    Condon, Bradley
    Ashok, Sheela
    Lu, Zhohai
    Ehlhardt, William
    Raub, Tom
    Lai, Mei
    Geeganage, Sandaruwan
    Burkholder, Timothy P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891
  • [8] Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
    Hu, Dennis X.
    Patel, Snahel
    Chen, Huifen
    Wang, Shumei
    Staben, Steven T.
    Dimitrova, Yoana N.
    Wallweber, Heidi Ackerly
    Lee, Joanna Y.
    Chan, Grace Ka Yan
    Sneeringer, Christopher J.
    Prangley, Madeleine S.
    Moffat, John G.
    Wu, Kai C.
    Schutt, Leah K.
    Salphati, Laurent
    Pang, Jodie
    McNamara, Erin
    Huang, Haochu
    Chen, Yong
    Wang, Yunli
    Zhao, Wensheng
    Lim, Junghyun
    Murthy, Aditya
    Siu, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, : 11500 - 11512
  • [9] N-alkylated diaryl pyrazoles: Selective Aurora kinase inhibitors
    Ralph, Jeffrey M.
    Feng, Yanhong
    Faitg, Thomas H.
    Silva, Domingos J.
    Adams, Jerry L.
    Hardwicke, Mary Ann
    Wang, Jamin
    Oleykowski, Catherine
    Diamond, Melody
    Sutton, David
    Faucette, Leo
    Plant, Ramona
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [10] N-Alkylated diaryl pyrazoles: Selective Aurora kinase inhibitors
    Ralph, Jeffrey
    Feng, Yanhong
    Silva, Domingos
    Adams, Jerry
    Faitg, Thomas
    Hardwicke, Mary Ann
    Wang, Jamin
    Oleykowski, Catherine
    Diamond, Melody
    Sutton, David
    Faucette, Leo
    Plant, Ramona
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243